Skip to main content
Erschienen in: Internal and Emergency Medicine 6/2019

25.03.2019 | IM - ORIGINAL

Is echocardiography mandatory for patients with chronic kidney disease?

verfasst von: Emilio Nardi, Giuseppe Mulè, Chiara Nardi, Giulio Geraci, Antonina Giammanco, Riccardo Bentivegna, Maurizio Averna

Erschienen in: Internal and Emergency Medicine | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

This study aims at evaluating the prevalence of left ventricular diastolic dysfunction in a group of 319 hypertensive patients with stage 3b–4–5 chronic kidney disease (according to Kidney Disease Improving Global Outcomes classification), compared with 216 patients with essential hypertension and normal renal function. All patients underwent echocardiographic examination. Patients on stage 1–2–3a chronic kidney disease, dialysis treatment, or with previous manifestations of heart failure or other cardiovascular diseases were excluded. Patients with renal disease had significantly worse diastolic function (both considering trans-mitral flow and tissue Doppler imaging parameters). Diastolic dysfunction is found in 70.5% of the CKD group and in 41.6% of hypertensive patients (p < 0.0001). Multiple regression analysis shows an association between renal function and diastolic function (β 0.223; p < 0.0001), independent of potential confounders. Our study shows that diastolic dysfunction is highly prevalent in patients with advanced chronic kidney disease; we posit that in this population, the risk of diastolic heart failure is very high. We think that patients with a marked decrease of glomerular filtration rate (GFR) must be considered at high risk for diastolic heart failure and should have an echocardiographic examination performed, even if asymptomatic and in the absence of evident cardiovascular disease.
Literatur
1.
Zurück zum Zitat Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRefPubMed
2.
Zurück zum Zitat Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J (2007) Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 18:1307–1315CrossRefPubMed Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J (2007) Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 18:1307–1315CrossRefPubMed
3.
Zurück zum Zitat Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG (2012) Chronic renal insufficiency cohort (CRIC) study group: associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23(10):1725–1734 (Epub 2012 Aug 30) CrossRefPubMedPubMedCentral Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG (2012) Chronic renal insufficiency cohort (CRIC) study group: associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23(10):1725–1734 (Epub 2012 Aug 30) CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG (2005) Cardiovascular Health S; Cardiovascular Health Study: cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142:497–505CrossRefPubMed Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG (2005) Cardiovascular Health S; Cardiovascular Health Study: cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142:497–505CrossRefPubMed
5.
Zurück zum Zitat Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145:237–246CrossRefPubMed Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145:237–246CrossRefPubMed
6.
Zurück zum Zitat Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ (1997) Assessing diagnosis in heart failure: which features are any use? QJM 90:335–339CrossRefPubMed Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ (1997) Assessing diagnosis in heart failure: which features are any use? QJM 90:335–339CrossRefPubMed
7.
Zurück zum Zitat Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, Mant D, McManus RJ, Holder R, Deeks J, Fletcher K, Qume M, Sohanpal S, Sanders S, Hobbs FD (2009) Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 13:1–207CrossRefPubMed Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, Mant D, McManus RJ, Holder R, Deeks J, Fletcher K, Qume M, Sohanpal S, Sanders S, Hobbs FD (2009) Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 13:1–207CrossRefPubMed
8.
Zurück zum Zitat Oudejans I, Mosterd A, Bloemen JA, Valk MJ, van Velzen E, Wielders JP, Zuithoff NP, Rutten FH, Hoes AW (2011) Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail 13:518–527CrossRef Oudejans I, Mosterd A, Bloemen JA, Valk MJ, van Velzen E, Wielders JP, Zuithoff NP, Rutten FH, Hoes AW (2011) Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail 13:518–527CrossRef
9.
10.
Zurück zum Zitat Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW (2011) The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 124:2865–2873CrossRefPubMed Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW (2011) The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 124:2865–2873CrossRefPubMed
11.
Zurück zum Zitat The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200CrossRef The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200CrossRef
12.
Zurück zum Zitat Owan TE, Hodge DO, Herges RM et al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259CrossRef Owan TE, Hodge DO, Herges RM et al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259CrossRef
13.
Zurück zum Zitat Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 32:670–679CrossRefPubMed Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 32:670–679CrossRefPubMed
14.
Zurück zum Zitat The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2018) 2018 Guidelines for the management of arterial hypertension. Eur Heart J 39:3021–3104CrossRef The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2018) 2018 Guidelines for the management of arterial hypertension. Eur Heart J 39:3021–3104CrossRef
15.
Zurück zum Zitat American Diabetes Association (2018) Classification and diagnosis of diabetes : standards of medical cares in diabetes. Diabetes Care 41(1):13–27CrossRef American Diabetes Association (2018) Classification and diagnosis of diabetes : standards of medical cares in diabetes. Diabetes Care 41(1):13–27CrossRef
16.
Zurück zum Zitat KDIGO 2012 (2013) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):56 KDIGO 2012 (2013) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):56
17.
Zurück zum Zitat Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1073CrossRefPubMed Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1073CrossRefPubMed
18.
Zurück zum Zitat Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed
19.
Zurück zum Zitat Skiller N, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367CrossRef Skiller N, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367CrossRef
20.
Zurück zum Zitat Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA (2002) Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15:167–184CrossRefPubMed Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA (2002) Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15:167–184CrossRefPubMed
21.
Zurück zum Zitat Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ et al (2000) Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol 36:891–896CrossRefPubMed Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ et al (2000) Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol 36:891–896CrossRefPubMed
22.
Zurück zum Zitat Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH et al (1997) Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30:474–480CrossRefPubMed Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH et al (1997) Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30:474–480CrossRefPubMed
23.
Zurück zum Zitat Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788–1794CrossRefPubMed Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788–1794CrossRefPubMed
24.
Zurück zum Zitat Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG (2004) Predictors of heart failure among women with coronary disease. Circulation 110:1424–1430CrossRefPubMed Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG (2004) Predictors of heart failure among women with coronary disease. Circulation 110:1424–1430CrossRefPubMed
25.
Zurück zum Zitat Chae CU, Albert CM, Glynn RJ, Guralnik JM, Curhan GC (2003) Mild renal insufficiency and risk of congestive heart failure in men and women ≥ 70 years of age. Am J Cardiol 92:682–686CrossRefPubMed Chae CU, Albert CM, Glynn RJ, Guralnik JM, Curhan GC (2003) Mild renal insufficiency and risk of congestive heart failure in men and women ≥ 70 years of age. Am J Cardiol 92:682–686CrossRefPubMed
26.
Zurück zum Zitat Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G (2005) Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 46:320–327CrossRefPubMed Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G (2005) Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 46:320–327CrossRefPubMed
27.
Zurück zum Zitat Middleton RJ, Parfrey PS, Foley RN (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12:1079–1084PubMed Middleton RJ, Parfrey PS, Foley RN (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12:1079–1084PubMed
28.
Zurück zum Zitat Nardi E, Palermo A, Mulè G, Cusimano P, Cottone S, Cerasola G (2009) Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 27:633–641CrossRefPubMed Nardi E, Palermo A, Mulè G, Cusimano P, Cottone S, Cerasola G (2009) Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 27:633–641CrossRefPubMed
29.
Zurück zum Zitat Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al (2007) 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187CrossRefPubMed Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al (2007) 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187CrossRefPubMed
30.
Zurück zum Zitat Cerasola G, Nardi E, Palermo A, Mule G, Cottone S (2011) Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol 24:1–10CrossRefPubMed Cerasola G, Nardi E, Palermo A, Mule G, Cottone S (2011) Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol 24:1–10CrossRefPubMed
31.
Zurück zum Zitat Cottone S, Nardi E, Mule G, Vadalà A, Lorito MC, Riccobne R et al (2007) Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol 67:209–216CrossRefPubMed Cottone S, Nardi E, Mule G, Vadalà A, Lorito MC, Riccobne R et al (2007) Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol 67:209–216CrossRefPubMed
32.
Zurück zum Zitat Cottone S, Lorito MC, Riccobene R, Nardi E, Mulè G, Buscemi S et al (2008) Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 21:175–179PubMed Cottone S, Lorito MC, Riccobene R, Nardi E, Mulè G, Buscemi S et al (2008) Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 21:175–179PubMed
33.
Zurück zum Zitat Mulè G, Nardi E, Guarino L, Cacciatore V, Geraci G, Calcaterra I et al (2015) Plasma aldosterone and its relationships with left ventricular mass in hypertensive patients with early stage chronic kidney disease. Hypertens Res 38:276–283CrossRefPubMed Mulè G, Nardi E, Guarino L, Cacciatore V, Geraci G, Calcaterra I et al (2015) Plasma aldosterone and its relationships with left ventricular mass in hypertensive patients with early stage chronic kidney disease. Hypertens Res 38:276–283CrossRefPubMed
34.
35.
Zurück zum Zitat Sato B, Yoshikawa D, Ishii H, Suzuki S, Inoue Y, Takeshita K et al (2013) Relation of plasma indoxyl sulfate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunction. Am J Cardiol 111:712–716CrossRefPubMed Sato B, Yoshikawa D, Ishii H, Suzuki S, Inoue Y, Takeshita K et al (2013) Relation of plasma indoxyl sulfate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunction. Am J Cardiol 111:712–716CrossRefPubMed
Metadaten
Titel
Is echocardiography mandatory for patients with chronic kidney disease?
verfasst von
Emilio Nardi
Giuseppe Mulè
Chiara Nardi
Giulio Geraci
Antonina Giammanco
Riccardo Bentivegna
Maurizio Averna
Publikationsdatum
25.03.2019
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 6/2019
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02028-0

Weitere Artikel der Ausgabe 6/2019

Internal and Emergency Medicine 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.